Join the Discussions on Biologically Informed Models of Combination Therapies: Apply by Nov. 22

Combination therapies are essential for cancer treatment.  If you are treating cancer patients, researching the biology underlying cancer, or investigating new medications or drug combinations, please consider applying for an “Ideas Lab” hosted by NCI’s Division of Cancer Biology and IBM Research in San Jose, CA. The event will take place January 24–28, 2022, but the application deadline is Monday, November 22.

The Ideas Lab will bring together experts in cancer and computational biology to address the complexity at the core of combination therapy interventions. Through collaborative sessions, attendees will have the opportunity to develop frameworks concerning new pilot projects that integrate computational models and ex-vivo experimental models, therapy mechanism of action, and patient outcomes.

Due to the highly interactive nature of this event, partial attendance is not allowed. Participants are required to attend the entire workshop.

If you have any questions, you may contact Dr. Jennifer Couch for additional information.

Vote below about this page’s helpfulness.